Developing vaccines to protect against influenza outbreaks
Official title: Advanced Development of Universal Vaccines for Universal Influenza
Funded at Versatope Therapeutics, INC. · NIH-11083536 · Data updated 2026-11-12
This study is working on making new vaccines that can protect against different types of the flu, especially during outbreaks, so that people can have better defense against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versatope Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Lowell, UNITED STATES) |
| Project start | September 9, 2019 |
| Project end | April 29, 2027 |
| Funding year | 2024 |
| Award (this year) | $3,608,426 |
| NIH project number | 75N93019C00060-P00025-9999-1 |
| Project ID | NIH-11083536 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at high risk for influenza, such as the elderly, immunocompromised individuals, and those with chronic health conditions.
✕Less likely to help
Patients who are not at risk for influenza or who have contraindications to vaccination may not receive benefit from this research.
What this research studies
This research focuses on creating universal vaccines that can effectively combat influenza, particularly in response to outbreaks caused by emerging infectious diseases. The approach involves formulating and manufacturing vaccine components, conducting stability tests, and performing immunogenicity and efficacy assessments in animal models. The research also includes evaluating the safety and effectiveness of these vaccines in clinical settings, aiming to provide a robust defense against influenza viruses. Patients may benefit from the development of vaccines that offer broader protection against various strains of the virus.
Why it matters
Potential benefit: If successful, this research could lead to the development of vaccines that provide widespread protection against influenza, potentially reducing the incidence of severe illness and outbreaks.
How similar studies have gone: Other research has shown promise in developing universal vaccines for influenza, indicating that this approach has potential for success.
Where this research is happening
-
Versatope Therapeutics, INC.
Lowell, United States Active
Researchers
- Principal investigator: Locher, Christopher — Versatope Therapeutics, INC.
- Study coordinator: Locher, Christopher
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Surveillance and preparedness for flu and other respiratory pathogens in Kenya
A US-based research grant aims to improve how Kenya detects and prepares for influenza and other respiratory diseases to protect people there and global health.
-
Enhanced Seasonal Influenza Vaccine Targeting Shared and Variable Viral Antigens
A new DNA-based influenza vaccine approach aims to provide both precise protection against circulating strains and broader defense against unexpected strains.
-
How the immune system responds to flu shots and flu infection
This project looks at how adults' immune systems react after flu shots or when they catch the flu to find why some people get better protection than others.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.